New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Alto Neuroscience, Inc. (ANRO) vs Inhibrx Biosciences, Inc. (INBX)
- Alto Neuroscience, Inc. ANRO 25.37 −4.30%
- Inhibrx Biosciences, Inc. INBX 68.97 −7.21%
Alto Neuroscience, Inc. and Inhibrx Biosciences, Inc. are both Biotechnology companies. Alto Neuroscience, Inc. and Inhibrx Biosciences, Inc. are of similar size ($1.1B and $1.1B). Across the 8 metrics below, Alto Neuroscience, Inc. leads on 5 and Inhibrx Biosciences, Inc. on 3.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack